Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,256 | -56,255 | -41,197 | -37,030 | -23,805 |
| Depreciation Amortization | 1,180 | 2,373 | 3,177 | 5,824 | 6,760 |
| Accounts receivable | -1,128 | 588 | 349 | -350 | -490 |
| Accounts payable and accrued liabilities | 552 | 567 | -2,082 | 1,480 | 638 |
| Other Working Capital | 11,026 | 13,261 | 4,803 | -3,126 | 1,574 |
| Other Operating Activity | -1,544 | 1,314 | 2,510 | -1,326 | -658 |
| Operating Cash Flow | $-35,170 | $-38,152 | $-32,440 | $-34,528 | $-15,981 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -357 | -24,260 | -36,135 | 21,126 | -17,921 |
| PPE Investments | -1,794 | -1,545 | -1,171 | -1,635 | -3,229 |
| Investing Cash Flow | $-2,151 | $-25,805 | $-37,306 | $19,491 | $-21,150 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 418 | N/A | N/A |
| Debt Issued | 1,656 | 831 | 1,351 | 1,999 | 1,748 |
| Debt Repayment | -1,556 | -2,224 | -3,557 | -3,712 | -3,047 |
| Common Stock Issued | 103,505 | 66,224 | 54,620 | 31,797 | 888 |
| Financing Cash Flow | $103,605 | $64,831 | $52,832 | $30,084 | $-411 |
| Beginning Cash Position | 10,495 | 9,621 | 26,535 | 11,488 | 49,030 |
| End Cash Position | 76,779 | 10,495 | 9,621 | 26,535 | 11,488 |
| Net Cash Flow | $66,284 | $874 | $-16,914 | $15,047 | $-37,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,170 | -38,152 | -32,440 | -34,528 | -15,981 |
| Capital Expenditure | -1,794 | -1,545 | -1,242 | -1,635 | -3,229 |
| Free Cash Flow | -36,964 | -39,697 | -33,682 | -36,163 | -19,210 |